Vanessa Grubbs1, Delphine S Tuot2, Neil R Powe2, Donal O'Donoghue3, Catherine A Chesla4. 1. Department of Medicine, University of California, San Francisco, CA; Department of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, San Francisco, CA. Electronic address: vanessa.grubbs@ucsf.edu. 2. Department of Medicine, University of California, San Francisco, CA; Department of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, San Francisco, CA. 3. Salford Royal NHS Foundation Trust, Salford, United Kingdom; University of Manchester, Manchester, United Kingdom. 4. Department of Family Health Care Nursing, University of California, San Francisco, San Francisco, CA.
Abstract
BACKGROUND: Despite a growing body of literature suggesting that dialysis does not confer morbidity or mortality benefits for all patients with chronic kidney failure, the initiation and continuation of dialysis therapy in patients with poor prognosis is commonplace. Our goal was to elicit nephrologists' perspectives on factors that affect decision making regarding end-stage renal disease. STUDY DESIGN: Semistructured, individual, qualitative interviews. METHODOLOGY: Participants were purposively sampled based on age, race, sex, geographic location, and practice type. Each was asked about his or her perspectives and experiences related to foregoing and withdrawing dialysis therapy. ANALYTICAL APPROACH: Interviews were audiotaped, transcribed, and analyzed using narrative and thematic analysis. RESULTS: We conducted 59 semistructured interviews with nephrologists from the United States (n=41) and England (n=18). Most participants were 45 years or younger, men, and white. Average time since completing nephrology training was 14.2±11.6 (SD) years. Identified system-level facilitators and barriers for foregoing and withdrawing dialysis therapy stemmed from national and institutional policies and structural factors, how providers practice medicine (the culture of medicine), and beliefs and behaviors of the public (societal culture). In both countries, the predominant barriers described included lack of training in end-of-life conversations and expectations for aggressive care among non-nephrologists and the general public. Primary differences included financial incentives to dialyze in the United States and widespread outpatient conservative management programs in England. LIMITATIONS: Participants' views may not fully capture those of all American or English nephrologists. CONCLUSIONS: Nephrologists in the United States and England identified several system-level factors that both facilitated and interfered with decision making around foregoing and withdrawing dialysis therapy. Efforts to expand facilitators while reducing barriers could lead to care practices more in keeping with patient prognosis.
BACKGROUND: Despite a growing body of literature suggesting that dialysis does not confer morbidity or mortality benefits for all patients with chronic kidney failure, the initiation and continuation of dialysis therapy in patients with poor prognosis is commonplace. Our goal was to elicit nephrologists' perspectives on factors that affect decision making regarding end-stage renal disease. STUDY DESIGN: Semistructured, individual, qualitative interviews. METHODOLOGY: Participants were purposively sampled based on age, race, sex, geographic location, and practice type. Each was asked about his or her perspectives and experiences related to foregoing and withdrawing dialysis therapy. ANALYTICAL APPROACH: Interviews were audiotaped, transcribed, and analyzed using narrative and thematic analysis. RESULTS: We conducted 59 semistructured interviews with nephrologists from the United States (n=41) and England (n=18). Most participants were 45 years or younger, men, and white. Average time since completing nephrology training was 14.2±11.6 (SD) years. Identified system-level facilitators and barriers for foregoing and withdrawing dialysis therapy stemmed from national and institutional policies and structural factors, how providers practice medicine (the culture of medicine), and beliefs and behaviors of the public (societal culture). In both countries, the predominant barriers described included lack of training in end-of-life conversations and expectations for aggressive care among non-nephrologists and the general public. Primary differences included financial incentives to dialyze in the United States and widespread outpatient conservative management programs in England. LIMITATIONS: Participants' views may not fully capture those of all American or English nephrologists. CONCLUSIONS: Nephrologists in the United States and England identified several system-level factors that both facilitated and interfered with decision making around foregoing and withdrawing dialysis therapy. Efforts to expand facilitators while reducing barriers could lead to care practices more in keeping with patient prognosis.
Authors: Mark Lambie; Hugh C Rayner; Jennifer L Bragg-Gresham; Ronald L Pisoni; Vittorio E Andreucci; Bernard Canaud; Friedrich K Port; Eric W Young Journal: Nephrol Dial Transplant Date: 2006-07-04 Impact factor: 5.992
Authors: Vanessa Grubbs; Alvin H Moss; Lewis M Cohen; Michael J Fischer; Michael J Germain; S Vanita Jassal; Jeffrey Perl; Daniel E Weiner; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2014-08-07 Impact factor: 8.237
Authors: Sara A Combs; Stacey Culp; Daniel D Matlock; Jean S Kutner; Jean L Holley; Alvin H Moss Journal: Am J Kidney Dis Date: 2014-09-20 Impact factor: 8.860
Authors: Jean L Holley; Sharon S Carmody; Alvin H Moss; Amy M Sullivan; Lewis M Cohen; Susan D Block; Robert M Arnold Journal: Am J Kidney Dis Date: 2003-10 Impact factor: 8.860
Authors: Shahid M Chandna; Maria Da Silva-Gane; Catherine Marshall; Paul Warwicker; Roger N Greenwood; Ken Farrington Journal: Nephrol Dial Transplant Date: 2010-11-22 Impact factor: 5.992
Authors: Manjula Kurella Tamura; Ann M O'Hare; Eugene Lin; Laura M Holdsworth; Elizabeth Malcolm; Alvin H Moss Journal: Am J Kidney Dis Date: 2018-03-03 Impact factor: 8.860
Authors: Susan P Y Wong; Saritha Boyapati; Ruth A Engelberg; Bjorg Thorsteinsdottir; Janelle S Taylor; Ann M O'Hare Journal: Am J Kidney Dis Date: 2019-09-27 Impact factor: 8.860
Authors: Keren Ladin; Renuka Pandya; Allison Kannam; Rohini Loke; Tira Oskoui; Ronald D Perrone; Klemens B Meyer; Daniel E Weiner; John B Wong Journal: Am J Kidney Dis Date: 2018-02-01 Impact factor: 8.860
Authors: Sarbjit V Jassal; Maria Larkina; Kitty J Jager; Fliss E M Murtagh; Ann M O'Hare; Norio Hanafusa; Hal Morgenstern; Friedrich K Port; Keith McCullough; Ronald Pisoni; Francesca Tentori; Rachel Perlman; Richard D Swartz Journal: CMAJ Date: 2020-08-31 Impact factor: 8.262
Authors: Devika Nair; Maie El-Sourady; Kemberlee Bonnet; David G Schlundt; Joseph B Fanning; Mohana B Karlekar Journal: J Palliat Med Date: 2020-02-11 Impact factor: 2.947
Authors: Yumeng Wen; Changchuan Jiang; Holly M Koncicki; Carol R Horowitz; Richard S Cooper; Aparna Saha; Steven G Coca; Girish N Nadkarni; Lili Chan Journal: J Am Soc Nephrol Date: 2019-08-06 Impact factor: 10.121
Authors: Keren Ladin; Renuka Pandya; Ronald D Perrone; Klemens B Meyer; Allison Kannam; Rohini Loke; Tira Oskoui; Daniel E Weiner; John B Wong Journal: Clin J Am Soc Nephrol Date: 2018-07-26 Impact factor: 8.237
Authors: Susan P Y Wong; Lynne V McFarland; Chuan-Fen Liu; Ryan J Laundry; Paul L Hebert; Ann M O'Hare Journal: JAMA Intern Med Date: 2019-03-01 Impact factor: 21.873
Authors: Sarah J Ramer; Natalie N McCall; Cassianne Robinson-Cohen; Edward D Siew; Huzaifah Salat; Aihua Bian; Thomas G Stewart; Maie H El-Sourady; Mohana Karlekar; Loren Lipworth; T Alp Ikizler; Khaled Abdel-Kader Journal: J Am Soc Nephrol Date: 2018-11-01 Impact factor: 10.121